TrialBMC veterinary research2018

Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma.

Abbey R Sadowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.